Comparison of Serum Concentrations of Bevacizumab and Vascular Endothelial Growth Factor (VEGF) Levels in Laser and Bevacizumab Treated ROP Patients

被引：0
|
作者：
Kong, Lingkun [1 ]
Bhatt, Amit R. [1 ]
Demny, Ann B. [1 ]
Steinkuller, Paul G. [1 ]
机构：
[1] Baylor Coll Med, Ophthalmol, Houston, TX 77030 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
706 retinopathy of prematurity; 578; laser; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5926
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity
    Sato, Tatsuhiko
    Wada, Kazuko
    Arahori, Hitomi
    Kuno, Noriyuki
    Imoto, Kenji
    Iwahashi-Shima, Chiharu
    Kusaka, Shunji
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (02) : 327 - 333
  • [2] HYPERTENSION IN PATIENTS TREATED WITH BEVACIZUMAB (MONOCLONAL ANTIBODY TO VASCULAR ENDOTHELIAL GROWTH FACTOR)
    Marina, I.
    Marcuello, E.
    Soler, M. J.
    Roca-Cusach, A.
    [J]. JOURNAL OF HYPERTENSION, 2009, 27 : S434 - S434
  • [3] Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis
    Gagné, D
    Pagé, M
    Robitaille, G
    Hugo, P
    Gosselin, D
    [J]. HUMAN REPRODUCTION, 2003, 18 (08) : 1674 - 1680
  • [4] Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients
    Beer, Paul M.
    Wong, Susan J.
    Hammad, Amjad M.
    Falk, Naomi S.
    O'Malley, Martin R.
    Khan, Samira
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08): : 871 - 876
  • [5] Serum ischemia modified albumin and vascular endothelial growth factor levels following intravitreal bevacizumab injections
    Soiberman, Uri
    Levy, Ran
    Schwartz, Shulamit
    Goldstein, Michaella
    Loewenstein, Anat
    Barak, Adiel
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (04) : 570 - 575
  • [6] Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: From the biology to the clinic
    Ranieri, Girolamo
    Patruno, Rosa
    Ruggieri, Eustachio
    Montemurro, Severino
    Valerio, Paolo
    Ribatti, Domenico
    [J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (16) : 1845 - 1857
  • [7] Analysis of the binding affinity of vascular endothelial growth factor A (VEGF) to ranibizumab, aflibercept and bevacizumab
    Wang, Xiangdan
    Yang, Jihong
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [8] Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    Nicholas Papadopoulos
    Joel Martin
    Qin Ruan
    Ashique Rafique
    Michael P. Rosconi
    Ergang Shi
    Erica A. Pyles
    George D. Yancopoulos
    Neil Stahl
    Stanley J. Wiegand
    [J]. Angiogenesis, 2012, 15 : 171 - 185
  • [9] Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    Papadopoulos, Nicholas
    Martin, Joel
    Ruan, Qin
    Rafique, Ashique
    Rosconi, Michael P.
    Shi, Ergang
    Pyles, Erica A.
    Yancopoulos, George D.
    Stahl, Neil
    Wiegand, Stanley J.
    [J]. ANGIOGENESIS, 2012, 15 (02) : 171 - 185
  • [10] EVALUATION OF SERUM CONCENTRATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN BREAST CANCER PATIENTS
    Hodorowicz-Zaniewska, Diana
    Kibil, Wojciech
    Malek, Agnieszka
    Szpor, Joanna
    Kulig, Jan
    Sztefko, Krystyna
    [J]. POLISH JOURNAL OF PATHOLOGY, 2012, 63 (04) : 255 - 260
12345